Trump’s rescheduling order boosts medical-grade CBD, but leaves retail market exposed
The executive order signed by U.S. President Donald Trump directing federal agencies to reschedule cannabis is expected to benefit hemp-derived CBD medicine, while doing little to legitimize the vast over-the-counter
Trump’s rescheduling order boosts medical-grade CBD, but leaves retail market exposed Read More »










